查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2077023

2026年電腦斷層掃描（CT）引導切片檢查全球市場報告

Computed Tomography (CT)-Guided Biopsy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，電腦斷層掃描（CT）引導切片檢查市場發展迅速。預計該市場規模將從2025年的7.7億美元成長到2026年的8.2億美元，複合年成長率（CAGR）為6.4%。過去幾年成長要素包括全球癌症發生率上升、診斷影像技術普及率提高、醫院放射科基礎設施擴建、微創手術需求日益成長以及CT影像系統普及率提高。

預計未來幾年，電腦斷層掃描（CT）引導切片檢查市場將保持強勁成長，到2030年將達到10.6億美元，複合年成長率（CAGR）為6.6%。預測期內的成長要素包括：對早期癌症檢測的需求不斷成長、基於精準醫療的診斷方法不斷擴展、門診診斷中心數量增加、老年人口不斷成長且需要進行診斷程序，以及切片穿刺針技術的進步和手術安全性的提高。預測期內的主要趨勢包括：微創診斷技術在早期精準疾病檢測中的應用日益廣泛；腫瘤和感染疾病診斷領域對影像引導精準介入治療的需求不斷成長；為減輕醫院負擔，人們越來越傾向於選擇門診和門診切片檢查；介入放射科的擴張以提高CT引導手術的可及性；以及臨床工作流程中對早期篩檢和組織學診斷的日益重視。

癌症發生率的上升預計將推動CT引導切片檢查市場的成長。癌症患者數量的增加主要源自於人口老化，而人口老化是市場擴張的重要因素。這是因為老年人罹患固態腫瘤的風險較高，而實體腫瘤則需要精確快速的診斷確認。 CT引導切片檢查能夠滿足這一需求，它能夠對深部或解剖結構複雜的病變進行精確的組織取樣，尤其是在肺、肝、胰腺、腎臟和骨骼等器官中，這些器官僅靠影像學檢查往往不足以做出明確的診斷和製定治療方案。例如，根據總部位於法國、隸屬於世界衛生組織（WHO）的政府間機構－國際癌症研究機構（IARC）的數據，截至2024年4月，2022年全球整體報告的新增癌症病例約2000萬例，癌症相關死亡病例近1000萬例。人口統計預測顯示，到2050年，每年新增癌症病例預計將達到3,500萬例，比2022年增加77%。因此，癌症發生率的上升正在推動CT引導切片檢查市場的成長。

在CT導引切片檢查市場中，領導企業正致力於開發先進的導航技術，例如即時CT導航系統，以提高手術精度、減少輻射暴露並簡化工作流程。即時CT導航系統是整合的影像和引導平台，利用3D視覺化和電磁追蹤技術，幫助臨床醫師精準引導切片穿刺針到達目標病灶，同時最大限度地減少重複成像的需求。例如，2023年4月，美國醫療科技公司GE醫療發布了其CT導航解決方案。該系統提供即時3D CT成像，用於立體定位穿刺引導，例如在切片檢查、消融和引流等手術中。它採用電磁導航技術，能夠實現複雜的穿刺軌跡，幫助臨床醫生避開關鍵的解剖結構。此外，此解決方案透過提高目標定位精度並最大限度地減少確認掃描，從而降低輻射暴露和手術時間，進而提高介入手術的安全性和效率。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球電腦斷層掃描（CT）引導切片檢查市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧和自主智慧
    • 機器人與自主系統
    • 物聯網、智慧基礎設施、互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫療
  • 主要趨勢
    • 擴大微創診斷方法的應用，以便早期、準確地檢測疾病。
    • 腫瘤學和感染疾病診斷領域對影像導引精準干預的需求日益成長。
    • 門診和當日切片檢查手術的日益普及旨在減輕醫院的負擔。
    • 介入放射科的擴建改善了CT導引手術的進行。
    • 臨床工作流程中對癌症早期篩檢和基於組織的診斷越來越感興趣。

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷影像中心
  • 門診手術中心
  • 專業診斷診所
  • 研究和學術醫療機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球電腦斷層掃描（CT）導引切片檢查市場：PESTEL分析
  • 全球電腦斷層掃描（CT）引導切片檢查市場：規模、對比和成長率分析
  • 全球電腦斷層掃描（CT）引導切片檢查市場表現：規模與成長，2020-2025年
  • 全球電腦斷層掃描（CT）引導切片檢查市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 切片檢查方法
  • 粗針穿刺活體組織切片、細針穿刺切片檢查、真空輔助切片檢查、鑽孔切片檢查或骨骼切片檢查
  • 透過目標器官
  • 肺、肝、腎、骨骼、胰臟和其他標靶器官
  • CT影像方式
  • 常規CT、CT透視、錐狀射束CT、頻譜或雙能量CT
  • 不同的針頭系統
  • 同軸系統、非同軸系統、半自動系統、全自動系統
  • 最終用戶
  • 醫院、影像診斷中心、門診手術中心
  • 按類型細分：空芯針活體組織切片
  • 自動穿刺切片、影像導引穿刺切片、同軸穿刺切片、一次性穿刺切片
  • 按類型細分：細針穿刺切片檢查
  • 影像導引下細針穿刺切片切片檢查、內視鏡細針穿刺切片檢查切片檢查、經皮皮細針穿刺切片切片檢查、超音波導引下細針穿刺切片切片檢查
  • 按類型細分：真空輔助
  • 影像導引真空輔助切片檢查、立體定位真空輔助切片檢查、超音波引導真空輔助切片檢查、大容量真空輔助切片檢查
  • 按類型細分：三聚氰胺或骨
  • 骨髓穿刺切片檢查、影像導引下骨切片檢查、經皮骨切片檢查、整形外科骨切片檢查

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 電腦斷層掃描（CT）引導切片檢查市場：競爭格局和市場佔有率，2024年
  • 電腦斷層掃描（CT）引導切片檢查市場：公司估值矩陣
  • 電腦斷層掃描（CT）引導切片檢查市場：公司概況
    • Samsung Electronics
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Stryker Corporation
    • Medtronic PLC

第37章 其他大型企業和創新企業

  • Boston Scientific Inc., Becton Dickinson and Company, Siemens Healthineers, Agilent Technologies Inc., GE HealthCare Technologies, Canon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Fujifilm Corporation, Illumina Inc., Koninklijke Philips NV, Olympus Corporation, Hologic Inc., Teleflex Incorporated, Sysmex Corporation

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年電腦斷層掃描（CT）引導切片檢查市場：提供新機會的國家
  • 2030年電腦斷層掃描（CT）引導切片檢查市場：充滿新機會的細分市場
  • 電腦斷層掃描（CT）引導切片檢查市場展望（2030年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: HS4MCGBU01_G26Q2

Computed tomography (CT)-guided biopsy is a minimally invasive diagnostic procedure that uses real-time computed tomography imaging to precisely direct a needle into specific target areas within the body for the collection of tissue samples. This method allows accurate localization of lesions in complex or difficult-to-access anatomical regions, enhancing diagnostic precision while minimizing harm to surrounding healthy tissues. It is commonly applied to assess abnormalities such as tumors, infections, and inflammatory conditions by enabling detailed histopathological evaluation.

The primary biopsy techniques used in CT-guided biopsy include core needle biopsy, fine needle aspiration biopsy, vacuum-assisted biopsy, and trephine or bone biopsy. Core needle biopsy is a minimally invasive technique in which a hollow needle is guided by computed tomography imaging to obtain a cylindrical tissue sample for comprehensive pathological analysis. These procedures are commonly performed on target organs such as the lungs, liver, kidneys, bones, pancreas, and other anatomical sites. The procedures utilize several computed tomography modalities, including conventional computed tomography, computed tomography fluoroscopy, cone-beam computed tomography, and spectral or dual-energy computed tomography. Different needle systems employed in these biopsies include coaxial, non-coaxial, semi-automated, and fully automated systems. The key end users comprise hospitals, imaging centers, and ambulatory surgical centers.

Tariffs are affecting the computed tomography (CT)-guided biopsy market by increasing the expenses associated with imported imaging systems, biopsy needles, contrast agents, and precision-guided interventional accessories utilized in diagnostic procedures. This is driving up overall procedure costs and impacting procurement budgets, particularly in import-dependent regions such as Asia-Pacific and Latin America where advanced radiology equipment is primarily sourced from international manufacturers. Segments such as CT modalities and automated needle systems are the most impacted due to their dependence on high-precision imported components. However, tariffs are also promoting local manufacturing of medical imaging consumables, regional supply chain diversification, and greater investment in domestic radiology infrastructure, which are enhancing long-term accessibility and cost resilience.

The computed tomography (CT)-guided biopsy market research report is one of a series of new reports from The Business Research Company that provides computed tomography (CT)-guided biopsy market statistics, including computed tomography (CT)-guided biopsy industry global market size, regional shares, competitors with a computed tomography (CT)-guided biopsy market share, detailed computed tomography (CT)-guided biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the computed tomography (CT)-guided biopsy industry. This computed tomography (CT)-guided biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The computed tomography (CT)-guided biopsy market size has grown strongly in recent years. It will grow from $0.77 billion in 2025 to $0.82 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising global cancer incidence, increasing adoption of imaging-based diagnostics, expansion of hospital radiology infrastructure, growing preference for minimally invasive procedures, improved availability of ct imaging systems.

The computed tomography (CT)-guided biopsy market size is expected to see strong growth in the next few years. It will grow to $1.06 billion by 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for early-stage cancer detection, rising adoption of precision medicine-based diagnostics, expansion of outpatient diagnostic centers, growing aging population requiring diagnostic interventions, advancements in biopsy needle technologies and procedural safety. Major trends in the forecast period include increasing adoption of minimally invasive diagnostic procedures for early and accurate disease detection, rising demand for image-guided precision interventions in oncology and infection diagnosis, growing preference for outpatient and ambulatory biopsy procedures to reduce hospital burden, expansion of interventional radiology departments improving access to ct-guided procedures, increasing focus on early cancer screening and tissue-based diagnostics in clinical workflows.

The increasing incidence of cancer is expected to propel the growth of the CT-guided biopsy market going forward. The rise in cancer cases is primarily contributing to market expansion, driven by an expanding aging population, as older individuals face a higher risk of developing solid tumors that require accurate and timely diagnostic confirmation. CT-guided biopsy supports this requirement by enabling precise tissue sampling from deep-seated or anatomically complex lesions, particularly in organs such as the lung, liver, pancreas, kidney, and bone, where imaging alone is often insufficient for definitive diagnosis and treatment planning. For instance, in April 2024, according to the International Agency for Research on Cancer, a France-based intergovernmental organization forming part of the World Health Organization, there were approximately 20 million new cancer cases and nearly 10 million cancer-related deaths globally in 2022. Demographic projections indicate that the annual number of new cancer cases is expected to reach 35 million by 2050, representing a 77% increase compared to 2022. Therefore, the rising incidence of cancer is supporting and propelling the growth of the CT-guided biopsy market.

Leading companies operating in the CT-guided biopsy market are focusing on the development of advanced navigation technologies, such as real-time CT navigation systems, to enhance procedural accuracy, reduce radiation exposure, and improve workflow efficiency. Real-time CT navigation systems are integrated imaging and guidance platforms that utilize 3D visualization and electromagnetic tracking to assist clinicians in accurately guiding biopsy needles to target lesions while minimizing the need for repeated imaging. For example, in April 2023, GE HealthCare, a US-based medical technology company, introduced its CT-Navigation solution. The system provides real-time 3D CT imaging for stereotactic needle guidance across procedures such as biopsies, ablations, and drainage. It incorporates electromagnetic navigation technology that enables complex needle trajectories, allowing clinicians to avoid critical anatomical structures. Additionally, the solution reduces radiation dose and procedure time by minimizing the need for multiple control scans while improving targeting accuracy, thereby enhancing safety and efficiency in interventional procedures.

In April 2023, GE HealthCare, a United States-based medical technology company, acquired IMACTIS for an undisclosed amount. Through this acquisition, GE HealthCare enhanced its interventional guidance capabilities by integrating CT-based needle navigation technology to improve procedural accuracy, workflow efficiency, and radiation management. IMACTIS is a France-based provider of CT-guided interventional navigation solutions for minimally invasive procedures.

Major companies operating in the computed tomography (ct)-guided biopsy market are Samsung Electronics, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Stryker Corporation, Medtronic PLC, Boston Scientific Inc., Becton Dickinson and Company, Siemens Healthineers, Agilent Technologies Inc., GE HealthCare Technologies, Canon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Fujifilm Corporation, Illumina Inc., Koninklijke Philips N. V., Olympus Corporation, Hologic Inc., Teleflex Incorporated, Sysmex Corporation, QIAGEN N. V., Bio-Rad Laboratories Inc., Shimadzu Corporation, Merit Medical Systems Inc., Guerbet (GBT. PA)

North America was the largest region in the CT-guided biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computed tomography (CT)-guided biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the computed tomography (CT)-guided biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The CT-guided biopsy market includes revenues earned by entities by providing services such as ultrasound-guided biopsy, MRI-guided biopsy, stereotactic biopsy, fluoroscopy-guided biopsy, image-guided fine needle aspiration, core needle biopsy services, and interventional radiology biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Computed Tomography (CT)-Guided Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses computed tomography (ct)-guided biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for computed tomography (ct)-guided biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The computed tomography (ct)-guided biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Biopsy Technique: Core Needle Biopsy; Fine Needle Aspiration; Vacuum-Assisted; Trephine Or Bone
  • 2) By Target Organ: Lung; Liver; Kidney; Bone; Pancreas; Other Target Organs
  • 3) By CT Modality: Conventional CT; CT-Fluoroscopy; Cone-Beam CT; Spectral Or Dual-Energy CT
  • 4) By Needle System: Coaxial Systems; Non-Coaxial; Semi-Automated; Fully Automated
  • 5) By End User: Hospitals; Imaging Centers; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Core Needle Biopsy: Automated Core Needle Biopsy; Image Guided Core Needle Biopsy; Coaxial Core Needle Biopsy; Single Use Core Needle Biopsy
  • 2) By Fine Needle Aspiration: Image Guided Fine Needle Aspiration; Endoscopic Fine Needle Aspiration; Percutaneous Fine Needle Aspiration; Ultrasound Assisted Fine Needle Aspiration
  • 3) By Vacuum-Assisted: Image Guided Vacuum-Assisted Biopsy; Stereotactic Vacuum-Assisted Biopsy; Ultrasound Guided Vacuum-Assisted Biopsy; High Volume Vacuum-Assisted Biopsy
  • 4) By Trephine Or Bone: Bone Marrow Trephine Biopsy; Image Guided Bone Biopsy; Percutaneous Bone Biopsy; Orthopedic Bone Biopsy
  • Companies Mentioned: Samsung Electronics; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Stryker Corporation; Medtronic PLC; Boston Scientific Inc.; Becton Dickinson and Company; Siemens Healthineers; Agilent Technologies Inc.; GE HealthCare Technologies; Canon Inc.; Zimmer Biomet Holdings Inc.; Terumo Corporation; Fujifilm Corporation; Illumina Inc.; Koninklijke Philips N.V.; Olympus Corporation; Hologic Inc.; Teleflex Incorporated; Sysmex Corporation; QIAGEN N.V.; Bio-Rad Laboratories Inc.; Shimadzu Corporation; Merit Medical Systems Inc.; Guerbet (GBT.PA)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Computed Tomography (CT)-Guided Biopsy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Computed Tomography (CT)-Guided Biopsy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Computed Tomography (CT)-Guided Biopsy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Computed Tomography (CT)-Guided Biopsy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Robotics & Autonomous Systems
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Diagnostic Procedures For Early And Accurate Disease Detection
    • 4.2.2 Rising Demand Of Image-Guided Precision Interventions In Oncology And Infection Diagnosis
    • 4.2.3 Growing Preference For Outpatient And Ambulatory Biopsy Procedures To Reduce Hospital Burden
    • 4.2.4 Expansion Of Interventional Radiology Departments Improving Access To Ct-Guided Procedures
    • 4.2.5 Increasing Focus On Early Cancer Screening And Tissue-Based Diagnostics In Clinical Workflows

5. Computed Tomography (CT)-Guided Biopsy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Imaging Centers
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Diagnostic Clinics
  • 5.5 Research And Academic Medical Institutions

6. Computed Tomography (CT)-Guided Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Computed Tomography (CT)-Guided Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Computed Tomography (CT)-Guided Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Computed Tomography (CT)-Guided Biopsy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Computed Tomography (CT)-Guided Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Computed Tomography (CT)-Guided Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Computed Tomography (CT)-Guided Biopsy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Computed Tomography (CT)-Guided Biopsy Market Segmentation

  • 9.1. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Core Needle Biopsy, Fine Needle Aspiration, Vacuum-Assisted, Trephine Or Bone
  • 9.2. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Target Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lung, Liver, Kidney, Bone, Pancreas, Other Target Organs
  • 9.3. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Conventional CT, CT-Fluoroscopy, Cone-Beam CT, Spectral Or Dual-Energy CT
  • 9.4. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Needle System, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coaxial Systems, Non-Coaxial, Semi-Automated, Fully Automated
  • 9.5. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Imaging Centers, Ambulatory Surgical Centers
  • 9.6. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Core Needle Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Core Needle Biopsy, Image Guided Core Needle Biopsy, Coaxial Core Needle Biopsy, Single Use Core Needle Biopsy
  • 9.7. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Fine Needle Aspiration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Image Guided Fine Needle Aspiration, Endoscopic Fine Needle Aspiration, Percutaneous Fine Needle Aspiration, Ultrasound Assisted Fine Needle Aspiration
  • 9.8. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Vacuum-Assisted, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Image Guided Vacuum-Assisted Biopsy, Stereotactic Vacuum-Assisted Biopsy, Ultrasound Guided Vacuum-Assisted Biopsy, High Volume Vacuum-Assisted Biopsy
  • 9.9. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Trephine Or Bone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bone Marrow Trephine Biopsy, Image Guided Bone Biopsy, Percutaneous Bone Biopsy, Orthopedic Bone Biopsy

10. Computed Tomography (CT)-Guided Biopsy Market Regional And Country Analysis

  • 10.1. Global Computed Tomography (CT)-Guided Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Computed Tomography (CT)-Guided Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Computed Tomography (CT)-Guided Biopsy Market

  • 11.1. Asia-Pacific Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Computed Tomography (CT)-Guided Biopsy Market

  • 12.1. China Computed Tomography (CT)-Guided Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Computed Tomography (CT)-Guided Biopsy Market

  • 13.1. India Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Computed Tomography (CT)-Guided Biopsy Market

  • 14.1. Japan Computed Tomography (CT)-Guided Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Computed Tomography (CT)-Guided Biopsy Market

  • 15.1. Australia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Computed Tomography (CT)-Guided Biopsy Market

  • 16.1. Indonesia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Computed Tomography (CT)-Guided Biopsy Market

  • 17.1. South Korea Computed Tomography (CT)-Guided Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Computed Tomography (CT)-Guided Biopsy Market

  • 18.1. Taiwan Computed Tomography (CT)-Guided Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Computed Tomography (CT)-Guided Biopsy Market

  • 19.1. South East Asia Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Computed Tomography (CT)-Guided Biopsy Market

  • 20.1. Western Europe Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Computed Tomography (CT)-Guided Biopsy Market

  • 21.1. UK Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Computed Tomography (CT)-Guided Biopsy Market

  • 22.1. Germany Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Computed Tomography (CT)-Guided Biopsy Market

  • 23.1. France Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Computed Tomography (CT)-Guided Biopsy Market

  • 24.1. Italy Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Computed Tomography (CT)-Guided Biopsy Market

  • 25.1. Spain Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Computed Tomography (CT)-Guided Biopsy Market

  • 26.1. Eastern Europe Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Computed Tomography (CT)-Guided Biopsy Market

  • 27.1. Russia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Computed Tomography (CT)-Guided Biopsy Market

  • 28.1. North America Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Computed Tomography (CT)-Guided Biopsy Market

  • 29.1. USA Computed Tomography (CT)-Guided Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Computed Tomography (CT)-Guided Biopsy Market

  • 30.1. Canada Computed Tomography (CT)-Guided Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Computed Tomography (CT)-Guided Biopsy Market

  • 31.1. South America Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Computed Tomography (CT)-Guided Biopsy Market

  • 32.1. Brazil Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Computed Tomography (CT)-Guided Biopsy Market

  • 33.1. Middle East Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Computed Tomography (CT)-Guided Biopsy Market

  • 34.1. Africa Computed Tomography (CT)-Guided Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Computed Tomography (CT)-Guided Biopsy Market Regulatory and Investment Landscape

36. Computed Tomography (CT)-Guided Biopsy Market Competitive Landscape And Company Profiles

  • 36.1. Computed Tomography (CT)-Guided Biopsy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Computed Tomography (CT)-Guided Biopsy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Computed Tomography (CT)-Guided Biopsy Market Company Profiles
    • 36.3.1. Samsung Electronics Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

37. Computed Tomography (CT)-Guided Biopsy Market Other Major And Innovative Companies

  • Boston Scientific Inc., Becton Dickinson and Company, Siemens Healthineers, Agilent Technologies Inc., GE HealthCare Technologies, Canon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Fujifilm Corporation, Illumina Inc., Koninklijke Philips N.V., Olympus Corporation, Hologic Inc., Teleflex Incorporated, Sysmex Corporation

38. Global Computed Tomography (CT)-Guided Biopsy Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Computed Tomography (CT)-Guided Biopsy Market

41. Computed Tomography (CT)-Guided Biopsy Market High Potential Countries, Segments and Strategies

  • 41.1 Computed Tomography (CT)-Guided Biopsy Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Computed Tomography (CT)-Guided Biopsy Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Computed Tomography (CT)-Guided Biopsy Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer